Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes
Role of <i>CYP24A1</i>, <i>VDR</i> and <i>GC</i> gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes, Published online: 21 November 2017; doi:10.1038/tpj.2017.43
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2zXqpIo
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,